P2501Rivaroxaban combined with spironolactone attenuates cardiovascular remodeling due to hypoxia in pulmonary arterial hypertension

Autor:	Takehiro Yamaguchi, Yoshio Ijiri, Michio Asahi, Yasukatsu Izumi, Eiki Woo, Hideki Imano, Shota Matsumoto, Atsuo Nomura, K Yamamoto, Yoshikatsu Okada, Minoru Yoshiyama, Tetsuya Hayashi, Ryuji Kato, A Hosokawa
Rok vydání:	2018
Předmět:	medicine.medical_specialty chemistry.chemical_compound chemistry business.industry Internal medicine medicine Cardiology Spironolactone Hypoxia (medical) medicine.symptom Cardiology and Cardiovascular Medicine business
Zdroj:	European Heart Journal. 39
ISSN:	1522-9645 0195-668X
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::29685d95f3a3ada3e3f666c9fd341a63 https://doi.org/10.1093/eurheartj/ehy565.p2501 Zobrazit plný text záznamu